Login to Your Account

Enzon, Micromet Collaborate On Single-Chain Antibody Program

By Kim Coghill

Friday, April 12, 2002
Enzon Inc. and Micromet AG signed a multiyear deal to combine their patents and knowledge to develop single-chain antibody therapeutics. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription